Back
Dynavax Technologies Corp. Stock Predictions
When an AI Platform Gets Pulled by Too Much Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
74
DVAX
Dynavax Technologies Corp.
Last Price:
$15.50
Seasonality Move:
-3.84%
7 Day Trial
ALL ACCESS PASS
$
7
1.5 Million Users. Zero Hype. Still Private.
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.comDynavax Technologies Corp. Stock Forecast
-
Over the next 52 weeks, Dynavax Technologies Corp. has on average historically risen by 21.2% based on the past 21 years of stock performance.
-
Dynavax Technologies Corp. has risen higher in 11 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.38%
-
Is Dynavax Technologies Corp. Stock Undervalued?The current Dynavax Technologies Corp. [DVAX] share price is $15.50. The Score for DVAX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
-
DVAX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Dynavax Technologies Corp. Stock Go Up Next Year?
-
Over the next 52 weeks, Dynavax Technologies Corp. has on average historically risen by 21.2% based on the past 21 years of stock performance.
Dynavax Technologies Corp. Stock Rating
Buy
74
Dynavax Technologies Corp. (DVAX)
is a Buy
Is Dynavax Technologies Corp. overpriced?
-
Dynavax Technologies Corp. has risen higher in 11 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.38%
Dynavax Technologies Corp. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
dynavax.com
52-Week Data
52-Week High:
15.73
52-Week Low:
9.20
Prediction Charts
Market Cap:
1.8B
Price in USD:
15.50
Volume:
2M
Beta:
1.90
Technical Analysis
SMA50:
13.69
SMA100:
12.00
SMA200:
11.19
52-Wk Change:
18.23%
Stock Predictions
-
Is Dynavax Technologies Corp. stock public?Yes, Dynavax Technologies Corp. is a publicly traded company.
-
What is the Dynavax Technologies Corp. stock quote today?The Dynavax Technologies Corp. stock price is 15.50 USD today.
-
How to buy Dynavax Technologies Corp. stock online?You can buy Dynavax Technologies Corp. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-20 | 15.63 | 15.68 | 15.69 | 15.61 |
| Jan-21 | 15.56 | 15.68 | 15.69 | 15.56 |
| Jan-22 | 15.68 | 15.65 | 15.69 | 15.65 |
| Jan-23 | 15.64 | 15.51 | 15.65 | 15.51 |
| Jan-26 | 15.51 | 15.52 | 15.56 | 15.49 |
| Jan-27 | 15.49 | 15.48 | 15.55 | 15.47 |
| Jan-28 | 15.50 | 15.48 | 15.51 | 15.48 |
| Jan-29 | 15.49 | 15.48 | 15.50 | 15.48 |
| Jan-30 | 15.48 | 15.49 | 15.50 | 15.47 |
| Feb-2 | 15.48 | 15.49 | 15.50 | 15.48 |
| Feb-3 | 15.46 | 15.48 | 15.49 | 15.46 |
| Feb-4 | 15.48 | 15.51 | 15.59 | 15.47 |
| Feb-5 | 15.50 | 15.49 | 15.50 | 15.49 |
| Feb-6 | 15.49 | 15.50 | 15.50 | 15.49 |
Dynavax Technologies Corp. Earnings
Dynavax Technologies Corp. Earnings Report: Per Share Dynavax Technologies Corp. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Dynavax Technologies Corp. Forecast Revenue Growth
Dynavax Technologies Corp. Stock Analysis: Historical quarterly revenues per share for Dynavax Technologies Corp. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.83 per share, and an increase next year of $0.11 per share.
* Dynavax Technologies Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.